News

Backed by an initial funding of $15 million from the National Science Foundation, the Regenerative Medicine Engine is the ...
U.S.-headquartered Alloy Therapeutics, a biotech firm focused on expanding access to drug discovery tools, said it has signed a memorandum of understanding with Serbia's state-owned operator of the ...
Roche and the African Society for Laboratory Medicine (ASLM) launch partnership to strengthen diagnostic leadership across ...
The life expectancy has increased in the U.S. and worldwide, contributing to healthcare companies retaining their patients ...
At Oak Ridge National Laboratory in Tennessee, a half-dozen workers are making what appear to be gray billiard balls. They're ...
In 2025, the 30 to 60-liter segment dominates the glass reactor market, accounting for approximately 4% of total revenue. The ...
The $300 million center in Iowa will turn locally grown corn into a plant-based chemical that can be used to make consumer ...
Johannes Fruehauf left Germany for the United States more than 20 years ago to propel his scientific career. But amid ...
Wave Life Sciences Ltd. (NASDAQ:WVE) is one of the best low priced pharma stocks to buy now. From June 20 to 23, Wave Life ...
Wacker Chemie has invested a double-digit million-euro amount in the new Wacker Biotechnology Center which is located in ...
One of the biggest barriers to the adoption of any new biotechnology tool is validation and regulatory clarity.
The federal government gutting university research funding reverses tradition that has served the U.S. well since World War ...